SOLITARIO ZINC CORP (XPL)       0.6812  +0.02 (+3.21%)

0.6812  +0.02 (+3.21%)

US8342EP1070 - Common Stock - After market: 0.682 +0 (+0.12%)


Fundamental Rating

We assign a fundamental rating of 3 out of 10 to XPL. XPL was compared to 1003 industry peers in the Metals & Mining industry. XPL has a great financial health rating, but its profitability evaluates not so good. XPL has a expensive valuation and it also scores bad on growth




Profitability

Profitability Rating


XPL has a Return On Assets of -10.02%. This is comparable to the industry average of -11.45%.
XPL has negative profitability rations, so we won't be analyzing them here.

XPL has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of XPL.
VS Industry

ROA (-10.02%) VS Industry: 53% outperformed.

-58,568.82
16,422.17

Valuation

Valuation Rating


When comparing the current price to the book value of XPL, we can conclude it is valued correctly. It is trading at 1.90 times its book value.
Compared to an average industry price book ratio of 1.83, XPL is valued in line with its industry peers.

The Price/Earnings Ratio is negative for XPL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for XPL. No positive earnings are expected for the next year.
VS Industry

Price/Book (1.9) VS Industry: 48% outperformed.

4,559.00
0.15

Growth

Growth Rating


XPL is expected to show quite a strong growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 13.37% yearly.
The earnings per share for XPL have decreased strongly by -149.67% in the last year.

Looking at the last year, XPL shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -149.67% -25% 23.93% 22.23% 13.37%
RevenueN/A N/A -100% N/A N/A N/A N/A

Health

Health Rating


A Current Ratio of 25.94 indicates that XPL has no problem at all paying its short term obligations.
The Current Ratio of XPL is much better than the industry average of 3.60. XPL has a better rating than 91% of its industry peers.
XPL has a Quick Ratio of 25.94. This indicates that XPL is financially healthy and has no problem in meeting its short term obligations.
XPL is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 3.19. XPL has a better rating than 91% of its industry peers.

XPL has an Altman-Z score of 55.90. This indicates that XPL is financially healthy and little risk of bankruptcy at the moment.
The Altman-Z score of XPL is much better than the industry average of 3.44. XPL has a better rating than 87% of its industry peers.
The Debt to Equity ratio of XPL is in line with the industry averages.
The Piotroski-F score of XPL is 3.00. This is a low score and indicates issues in the health and profitability of XPL.
VS Industry

Debt/Equity (0) VS Industry: 48% outperformed.

29.83
-90.09

Quick Ratio (25.94) VS Industry: 91% outperformed.

0.00
703.43

Current Ratio (25.94) VS Industry: 91% outperformed.

0.00
703.43

Altman-Z (55.9) VS Industry: 87% outperformed.

-72,242.07
708,925.94

Dividend

Dividend Rating


XPL does not give a dividend.

XPL Daily chart

SOLITARIO ZINC CORP0.6812

NYSEARCA:XPL (5/16/2022, 5:37:45 PM)+0.02 (+3.21%)

After market: 0.682 +0 (+0.12%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Metals & Mining
Earnings (Last) 04-12 2022-04-12/bmo Earnings (Next) 05-24 2022-05-24/bmo
Ins Owners 4.68% Inst Owners 10.6%
Market Cap 44.12M Analysts 80
Valuation
PE N/A Fwd PE N/A
PEG (NY) N/A PEG (5Y) N/A
P/S N/A P/B 1.9
EV/EBITDA -16.69
Profitability
ROA -10.02% ROE N/A
PM N/A Asset Turnover N/A
Growth
EPS 1Y -149.67% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q 14.34%
EPS Next Y -25% EPS Next 2Y 23.93%
EPS Next 3Y 22.23% EPS Next 5Y 13.37%
Revenue growth 1Y -100% Revenue growth 3Y N/A
Revenue growth 5Y N/A Revenue growth Q2Q N/A
Revenue Next Year N/A Revenue Next 2Y N/A
Revenue Next 3Y N/A Revenue Next 5Y N/A
Health
Current Ratio 25.94 Quick Ratio 25.94
Altman-Z 55.9 F-Score 3
Debt/Equity N/A
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA